查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
臨床前 CRO 全球市場研究報告 - 2023-2030 年行業分析、規模、份額、增長、趨勢和預測
市場調查報告書
商品編碼
1267312

臨床前 CRO 全球市場研究報告 - 2023-2030 年行業分析、規模、份額、增長、趨勢和預測

Global Preclinical CRO Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

全球對臨床前 CRO 市場的需求將從 2022 年的 90.9 億美元增長到 2030 年的近 209.8 億美元，預計 2023-2030 年研究期間的複合年增長率為 11.02%

臨床前 CRO(合同研究組織)是主要在製藥、生物技術和醫療設備領域提供研究和測試服務的公司。 這些服務通常在藥物開發的臨床前階段進行，即新藥在人體臨床試驗中進行測試之前的時期。 臨床前 CRO 服務包括範圍廣泛的活動，包括實驗室測試、動物測試和毒理學測試。 臨床前 CRO 公司通常擁有專門的實驗室和設施，以及訓練有素且精通各種科學學科的員工。

市場動態：

預計對新藥和醫療器械的監管要求不斷提高將提振市場。 新藥開發是一個漫長而昂貴的過程，需要大量的資源和專業知識。 製藥公司、生物技術公司和醫療設備製造商通常發現將部分研發外包給專業的 CRO 更具成本效益，這有望推動市場增長。 此外，對新藥和醫療的需求不斷增長正在推動市場增長。 CRO 在新藥和醫療器械的開發中發揮著關鍵作用，有助於確保藥物在上市前的安全性和有效性。 然而，在研發過程中使用動物可能會阻礙市場增長。

這份研究報告解釋了波特的五力模型、市場吸引力分析和價值鏈分析。 這些工具可幫助您清楚地了解您的行業結構並評估您在全球範圍內的競爭吸引力。 此外，這些工具還能夠全面評估全球臨床前CRO市場的各個細分市場。 臨床前 CRO 行業的發展和趨勢為這項研究提供了一種整體方法。

市場細分：

本部分按國家/地區提供詳細的細分數據，以幫助您確定每種產品/服務的目標受眾和未來商機。

按服務

  • 生物分析和 DMPK 測試(體外 ADME，體內 PK)
  • 毒理學測試(GLP、非 GLP)
  • 化合物管理(工藝研發、定制合成等)
  • 化學(藥物化學、計算化學)
  • 安全藥理學
  • 其他

按模型類型

  • 患者衍生的有機體 (PDO) 模型
  • 患者來源的異種移植模型

按最終用途

  • 生物製藥公司
  • 政府/學術機構
  • 醫療設備製造商

按地區分析：

本節涵蓋區域展望，重點關注北美、歐洲、亞太地區、拉丁美洲、中東和非洲臨床前 CRO 市場當前和未來的需求。 此外，它還側重於所有主要地區每個單獨應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的綜合概況和全球競爭格局的詳細視圖。 臨床前 CRO 市場的主要參與者是 SGS SA (SGS)、Charles River Laboratories International Inc.、Eurofins Scientific、PRA Health Sciences Inc.、Wuxi AppTec、Medpace Inc.、Pharmaceutical Product Development (PPD) LLC、Intertek Group Plc ( IGP ), Crown Bioscience, Laboratory Corporation of America Inc. 本節概述了競爭格局，包括各種戰略發展，例如主要併購、未來能力、合作夥伴關係、財務概覽、合作、新產品開發和新產品發布。它包括的大局。

內容

第1章前言

  • 報告內容
    • 目的
    • 目標受眾
    • USP(獨特的銷售建議)及其提供的內容
  • 調查範圍
  • 調查方法
    • 市場調研流程
    • 市場研究方法

第 2 章執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章臨床前 CRO - 行業分析

  • 簡介 - 市場動態
  • 市場驅動力
  • 市場製約因素
  • 機會
  • 行業趨勢
  • 波特的五力分析
  • 市場吸引力分析
    • 按服務分類的市場吸引力分析
    • 按模型類型進行市場吸引力分析
    • 按最終用途進行的市場吸引力分析
    • 市場吸引力分析：按地區

第四章價值鏈分析

  • 價值鏈分析
  • 原材料分析
    • 原材料清單
    • 原材料製造商列表
    • 主要原材料價格走勢
  • 潛在買家名單
  • 營銷渠道
    • 直接營銷
    • 間接營銷
    • 市場發展趨勢

第 5 章 COVID-19 爆發的影響分析

第 6 章臨床前 CRO 全球市場分析：按服務分類

  • 服務概覽
  • 過去和未來的數據
  • 服務分析
  • 生物分析和 DMPK 測試(體外 ADME、體內 PK)
  • 毒理學測試(GLP、非 GLP)
  • 化合物管理(工藝研發、定制合成等)
  • 化學(藥物化學、計算化學)
  • 安全藥理學
  • 其他

第 7 章臨床前 CRO 全球市場分析：按模型類型分類

  • 按模型類型概述
  • 過去和未來的數據
  • 按模型類型分析
  • 患者衍生的有機體 (PDO) 模型
  • 患者來源的異種移植模型

第 8 章全球臨床前 CRO 市場銷售分析(按最終用途)

  • 最終用戶總結
  • 過去和未來的數據
  • 最終用戶分析
  • 生物製藥公司
  • 政府/學術機構
  • 醫療設備製造商

第 9 章按地區分列的全球臨床前 CRO 市場銷售分析

  • 按地區進行的銷售前景分析
  • 介紹銷售分析
  • 北美銷售分析
    • 概覽、歷史和預測銷售分析
    • 北美各部門的銷售分析
    • 北美銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史和預測銷售分析
    • 按細分市場進行的歐洲銷售分析
    • 按國家/地區劃分的歐洲銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 意大利銷售分析
    • 俄羅斯銷售分析
    • 其他歐洲銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史和預測銷售分析
    • 亞太地區各部門的銷售分析
    • 亞太國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本的銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 其他亞太地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史和預測銷售分析
    • 拉丁美洲各部門的銷售分析
    • 拉丁美洲國家/地區的銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利的銷售分析
    • 其他拉丁美洲銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史和預測銷售分析
    • 中東和非洲各細分市場的銷售額分析
    • 中東和非洲國家/地區的銷售分析
    • 沙特阿拉伯銷售分析
    • 阿聯酋銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 其他中東和非洲銷售分析

第10章臨床前CRO公司的競爭格局

  • 臨床前 CRO 市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他擴展

第11章公司簡介

  • 前 10 名公司的市場份額分析
  • 市場集中度
  • SGS SA (SGS)
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • 查爾斯河實驗室國際公司
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • 歐陸科學
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • PRA 健康科學公司
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • 無錫艾普泰克
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • 美佩斯公司
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • 醫藥產品開發 (PPD) LLC
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • 天祥集團 (IGP)
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • 美國公司 Crown Bioscience and Laboratory Corporation
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢

注意：在公司簡介、財務細節、近期發展等方面，基於可用信息，私人控股公司可能不包括在內。

Product Code: VMR112110008

The global demand for Preclinical CRO Market is presumed to reach the market size of nearly USD 20.98 BN by 2030 from USD 9.09 BN in 2022 with a CAGR of 11.02% under the study period 2023 - 2030.

A preclinical CRO, or contract research organization, is a company that provides research and testing services to industries mainly in the field of pharmaceutical, biotechnology, and medical devices. These services are typically conducted during the preclinical stage of drug development, which refers to the period before a new drug is tested in human clinical trials. Preclinical CRO services can include a wide range of activities, such as laboratory testing, animal testing, and toxicology studies. Preclinical CRO companies typically have specialized laboratories and equipment and highly trained staff with expertise in various scientific fields.

Market Dynamics:

The increasing regulatory requirements for new drugs and medical devices are expected to raise the market. The development of a new drug is a long, expensive process that requires significant resources and expertise. Pharma, biotech, and medical device manufacturers often find it more cost-effective to outsource certain aspects of their research and development efforts to specialized CROs, which may drive market growth.Moreover, the increasing demand for new drugs and medical treatments boosts market growth. These companies play a vital role in developing new medicines and medical devices, assisting in ensuring the safety and effectiveness of the medicine before it is available to the public. However, the use of animals in the research and development process may hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of preclinical cro. The growth and trends of preclinical cro industry provide a holistic approach to this study.

Market Segmentation:

This section of the preclinical cro market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Service

  • Bioanalysis And Dmpk Studies (In Vitro ADME, In-Vivo PK)
  • Toxicology Testing (GLP, Non-GLP)
  • Compound Management (Process R&D, Custom Synthesis, Others)
  • Chemistry (Medicinal Chemistry, Computation Chemistry)
  • Safety Pharmacology
  • Others

By Model Type

  • Patient Derived Organoid (PDO) Model
  • Patient Derived Xenograft Model

By End-Use

  • Biopharmaceutical Companies
  • Government And Academic Institutes
  • Medical Device Companies

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Preclinical CRO market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the preclinical cro market include SGS SA (SGS), Charles River Laboratories International Inc., Eurofins Scientific, PRA Health Sciences Inc., Wuxi AppTec, Medpace Inc., Pharmaceutical Product Development (PPD) LLC, Intertek Group Plc (IGP), Crown Bioscience and Laboratory Corporation of America Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . PRECLINICAL CRO - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Service
    • 3.7.2 Market Attractiveness Analysis By Model Type
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL PRECLINICAL CRO MARKET ANALYSIS BY SERVICE

  • 6.1 Overview by Service
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Service
  • 6.4 Bioanalysis and DMPK studies (In vitro ADME, In-vivo PK) Historic and Forecast Sales by Regions
  • 6.5 Toxicology Testing (GLP, Non-GLP) Historic and Forecast Sales by Regions
  • 6.6 Compound Management (Process R&D, Custom Synthesis, Others) Historic and Forecast Sales by Regions
  • 6.7 Chemistry (Medicinal Chemistry, Computation Chemistry) Historic and Forecast Sales by Regions
  • 6.8 Safety Pharmacology Historic and Forecast Sales by Regions
  • 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL PRECLINICAL CRO MARKET ANALYSIS BY MODEL TYPE

  • 7.1 Overview by Model Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Model Type
  • 7.4 Patient Derived Organoid (PDO) Model Historic and Forecast Sales by Regions
  • 7.5 Patient Derived Xenograft Model Historic and Forecast Sales by Regions

8 . GLOBAL PRECLINICAL CRO MARKET SALES ANALYSIS BY END-USE

  • 8.1 Overview by End-use
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End-use
  • 8.4 Biopharmaceutical Companies Historic and Forecast Sales by Regions
  • 8.5 Government And Academic Institutes Historic and Forecast Sales by Regions
  • 8.6 Medical Device Companies Historic and Forecast Sales by Regions

9 . GLOBAL PRECLINICAL CRO MARKET SALES ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook Sales Analysis
  • 9.2. Introduction Sales Analysis
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE PRECLINICAL CRO COMPANIES

  • 10.1. Preclinical Cro Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF PRECLINICAL CRO INDUSTRY

  • 11.1. Top 10 Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. SGS SA (SGS)
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Charles River Laboratories International Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Eurofins Scientific
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. PRA Health Sciences Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Wuxi AppTec
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Medpace Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Pharmaceutical Product Development (PPD) LLC
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Intertek Group Plc (IGP)
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Crown Bioscience and Laboratory Corporation of America Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Service (USD MN)
  • Bioanalysis and DMPK studies (In vitro ADME, In-vivo PK) Market Sales by Geography (USD MN)
  • Toxicology Testing (GLP, Non-GLP) Market Sales by Geography (USD MN)
  • Compound Management (Process R&D, Custom Synthesis, Others) Market Sales by Geography (USD MN)
  • Chemistry (Medicinal Chemistry, Computation Chemistry) Market Sales by Geography (USD MN)
  • Safety Pharmacology Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Model Type (USD MN)
  • Patient Derived Organoid (PDO) Model Market Sales by Geography (USD MN)
  • Patient Derived Xenograft Model Market Sales by Geography (USD MN)
  • Analysis by End-use (USD MN)
  • Biopharmaceutical Companies Market Sales by Geography (USD MN)
  • Government And Academic Institutes Market Sales by Geography (USD MN)
  • Medical Device Companies Market Sales by Geography (USD MN)
  • Global Preclinical Cro Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Preclinical Cro Report
  • Market Research Process
  • Market Research Methodology
  • Global Preclinical Cro Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Service
  • Market Attractiveness Analysis by Model Type
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Service (USD MN)
  • Bioanalysis and DMPK studies (In vitro ADME, In-vivo PK) Market Sales by Geography (USD MN)
  • Toxicology Testing (GLP, Non-GLP) Market Sales by Geography (USD MN)
  • Compound Management (Process R&D, Custom Synthesis, Others) Market Sales by Geography (USD MN)
  • Chemistry (Medicinal Chemistry, Computation Chemistry) Market Sales by Geography (USD MN)
  • Safety Pharmacology Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Model Type (USD MN)
  • Patient Derived Organoid (PDO) Model Market Sales by Geography (USD MN)
  • Patient Derived Xenograft Model Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Biopharmaceutical Companies Market Sales by Geography (USD MN)
  • Government And Academic Institutes Market Sales by Geography (USD MN)
  • Medical Device Companies Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.